4th Antibody Symposium in Biopolis, Singapore
The 4th antibody symposium, co-organised by p53 Laboratory, A*STAR Biomedical Sciences Institutes and CPR, was held at Matrix, Biopolis with around 300 audiences. The symposium commenced with an opening address from Mr. Osamu Nagayama, Chairman and CEO of Chugai Pharmaceutical, followed by keynote lectures from Dr. Mark Davis, Stanford University and Prof. Tomohiro Kurosaki, Osaka University IFReC. Dr. Nezu, CPR Research Head, also showed the successful development of bispecific antibody project. CPR is honoured to help provide scientists in Biopolis with cutting-edge antibody research and encourage interaction among government, academia and industry.